Internal Medicine · Los Angeles, CA
NPI
1417008772
Since 2007
Specialty
Internal Medicine
Code 207R00000X
Group practices
8
Medicare group memberships
Hospitals
3
Hospital affiliations
1171 S Robertson Blvd, Suite #242
Los Angeles, CA, 90035
Phone (626) 765-4321
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.5M
22,547 services
Medicare patients, 2024
1,404
Average age 77
Drug cost, 2024
$2.7M
44,218 prescriptions
Company payments, 2025
$352
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Shahriar Jarchi was code G0316 (prolonged hospital inpatient or observation care evaluation and management service(s) beyond the total time for the primary service (when the primary service has been selected using time on the date of the primary service); each additional 15 minutes by th), 7,481 times for 546 patients. In total Shahriar Jarchi billed 22,547 services in 51 codes, and Medicare paid $1.5M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-07-18.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G0316 Prolonged hospital inpatient or observation care evaluation and management service(s) beyond the total time for the primary service (when the primary service has been selected using time on the date of the primary service); each additional 15 minutes by th | Facility | 7,481 | 546 | $25.01 | $187K |
| 99233 Hospital E&M - Subsequent | Facility | 5,951 | 537 | $97.50 | $580K |
| 99232 Hospital E&M - Subsequent | Facility | 5,080 | 471 | $64.88 | $330K |
| 99349 Home E&M - New and Established | Office | 889 | 354 | $83.43 | $74K |
| 99310 SNF E&M | Facility | 597 | 221 | $122.32 | $73K |
| 99223 Hospital E&M - Initial | Facility | 551 | 499 | $142.52 | $79K |
| 99309 SNF E&M | Facility | 445 | 195 | $80.44 | $36K |
| 99350 Home E&M - New and Established | Office | 187 | 109 | $153.88 | $29K |
| G0181 Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allow | Office | 174 | 83 | $86.70 | $15K |
| 99306 SNF E&M | Facility | 152 | 148 | $142.66 | $22K |
| G0180 Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 117 | 87 | $46.36 | $5,424 |
| 99291 Critical Care E&M | Facility | 106 | 70 | $173.08 | $18K |
| 99292 Critical Care E&M | Facility | 81 | 52 | $87.03 | $7,050 |
| 99348 Home E&M - New and Established | Office | 79 | 69 | $60.54 | $4,783 |
| G0179 Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 76 | 60 | $36.92 | $2,806 |
By year: 2022 $556K for 7,013 services; 2023 $1.1M for 14,655 services; 2024 $1.5M for 22,547 services.
Medicare prescription drug claims, 2024
In 2024, the drug Shahriar Jarchi prescribed most often to Medicare patients was Atorvastatin Calcium, with 2,982 prescriptions and refills. In total Shahriar Jarchi wrote 44,218 Medicare prescriptions that cost $2.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 2,982 | 3,184 | 393 | $35K |
| Amlodipine Besylate Generic | 1,813 | 1,940 | 252 | $12K |
| Gabapentin Generic | 1,662 | 1,736 | 210 | $19K |
| Levothyroxine Sodium Generic | 1,589 | 1,723 | 189 | $15K |
| Eliquis Apixaban | 1,378 | 1,440 | 135 | $500K |
| Metformin Hcl Generic | 1,191 | 1,294 | 159 | $9,231 |
| Tamsulosin Hcl Generic | 1,104 | 1,185 | 148 | $13K |
| Pantoprazole Sodium Generic | 961 | 1,003 | 159 | $17K |
| Losartan Potassium Generic | 896 | 979 | 116 | $8,188 |
| Furosemide Generic | 892 | 970 | 150 | $3,886 |
| Mirtazapine Generic | 829 | 880 | 120 | $15K |
| Donepezil Hcl Generic | 784 | 823 | 97 | $13K |
| Memantine Hcl Generic | 746 | 762 | 87 | $23K |
| Lisinopril Generic | 729 | 790 | 100 | $5,338 |
| Famotidine Generic | 728 | 763 | 96 | $6,537 |
Brand drugs: 5,119 claims; generic drugs: 38,574 claims; opioid claims: 888.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Shahriar Jarchi $352 ($352 in general payments such as food, travel and fees) from 9 companies. The largest payer was Novo Nordisk Inc with $63.3.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 2 | $63.3 |
| Lundbeck LLC | 2 | $61.51 |
| Abbvie Inc. ABBV | 2 | $58.8 |
| Merz North America, Inc. | 1 | $34.24 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 1 | $30.51 |
| Lilly USA, LLC LLY | 1 | $29.66 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 1 | $28.05 |
| Noven Therapeutics, LLC | 1 | $24.47 |
| Exact Sciences Corporation EXAS | 1 | $21.93 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.